Lin Chen
- Cancer Research top 0.5%
- MicroRNA in disease regulation 50
- Cancer-related molecular mechanisms research 34
- Immunology top 2%
- Molecular Biology top 1%
- Circular RNAs in diseases 34
- RNA modifications and cancer 16
- Glycosylation and Glycoproteins Research 11
- Oncology top 2%
- Cancer Cells and Metastasis 15
- Cancer-related Molecular Pathways 10
- Cell Biology top 5%
-
- Cancer Research and Treatments 11
- Co-authors
- Shanliang ZhongJianhua ZhaoJinhai TangAnjana RaoD.L. BatesYongqing WuDiane MathisJames C. Stroud
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lin Chen
214 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 2.6k
- Immunology 1.4k
- Molecular Biology 4.0k
- Oncology 1.4k
- Cell Biology 368
Countries citing papers authored by Lin Chen
This map shows the geographic impact of Lin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Chen more than expected).
Fields of papers citing papers by Lin Chen
This network shows the impact of papers produced by Lin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Chen. The network helps show where Lin Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 28 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 64 | |
| 12 | 2021 | 15 | |
| 13 | 2021 | 24 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 14 | |
| 16 | Clinical observation of Saifurun in the prevention of radiation dermatitis in patients with breast cancer | 2020 | 1 |
| 17 | 2016 | 55 | |
| 18 | 2015 | 38 | |
| 19 | 2013 | 68 | |
| 20 | [Inhibition of alphastatin on angiogenesis in human endothelial cells and the mechanism thereof: an experimental study]. | 2006 | 1 |
About Lin Chen
Lin Chen is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 227 papers that have together received 7.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (50 papers), Cancer-related molecular mechanisms research (34 papers), Circular RNAs in diseases (34 papers), RNA modifications and cancer (16 papers), Cancer Cells and Metastasis (15 papers), Cancer Research and Treatments (11 papers), Glycosylation and Glycoproteins Research (11 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Cancer Research (2.6k citations), Immunology (1.4k citations) and Molecular Biology (4.0k citations). Lin Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Shanliang Zhong, Jianhua Zhao, Jinhai Tang, Anjana Rao, D.L. Bates, Yongqing Wu, Diane Mathis, James C. Stroud, Xiaohui Du and Aidong Han. Their work appears in journals such as PLoS ONE, Cellular Physiology and Biochemistry, Oncotarget, Head & Neck and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.